vaccin
regim
infecti
bronchiti
viru
ibv
base
singl
viru
serotyp
often
induc
insuffici
level
crossprotect
serotyp
two
antigen
divers
vaccin
use
attempt
provid
broader
protect
amino
acid
differ
surfac
protein
spike
particular
subunit
associ
poor
crossprotect
homolog
vaccin
trial
recombin
ibv
ribv
base
apathogen
strain
beaur
conduct
elucid
role
protect
singl
vaccin
specificpathogenfre
chicken
ribv
express
virul
strain
qx
beaurqx
gave
incomplet
protect
homolog
challeng
base
ciliari
activ
clinic
sign
could
conform
issu
spike
heterolog
link
suggest
homolog
might
essenti
address
homolog
vaccinationchalleng
trial
incorpor
ribv
express
full
spike
subunit
conduct
chimer
virus
grew
similar
titer
vitro
induc
virusspecif
partial
protect
immun
evid
cellular
infiltr
reduct
viral
rna
load
trachea
conjunctiva
higher
serum
antiibv
titer
collect
find
show
vaccin
ribv
prime
bird
challeng
virus
clear
rapidli
mucos
tissu
head
chimer
virus
protect
effect
base
ciliari
activ
clinic
sign
booster
vaccin
ribv
improv
vivo
replic
may
improv
level
protect
import
infecti
bronchiti
viru
caus
acut
highli
contagi
respiratori
diseas
respons
signific
econom
loss
poultri
industri
amino
acid
differ
surfac
protein
spike
particular
subunit
associ
poor
crossprotect
avail
vaccin
give
poor
crossprotect
ration
design
live
attenu
vaccin
base
apathogen
beaur
could
address
determin
role
protect
seri
homolog
vaccin
trial
ribv
conduct
singl
vaccin
chimer
ribv
induc
virusspecif
partial
protect
immun
character
reduct
viral
load
serum
antibodi
titer
howev
vaccin
improv
level
protect
clinic
sign
loss
tracheal
ciliari
activ
growth
characterist
show
ribv
replic
vitro
similar
level
booster
vaccin
ribv
improv
vivo
replic
may
improv
level
protect
character
ribv
beaurqx
homolog
protect
determin
whether
singl
vaccin
ribv
express
subunit
gene
beaudett
deriv
subunit
suffici
induc
protect
challeng
homolog
pathogen
isol
ibv
vaccinationchalleng
trial
conduct
beaurqx
clinic
sign
loss
ciliari
activ
trachea
observ
either
vaccin
group
vaccin
data
shown
result
show
replac
beaur
gene
gene
pathogen
strain
confer
pathogen
result
beaurqx
virus
three
week
primari
inocul
chicken
challeng
homolog
wildtyp
viru
strain
qx
clinic
sign
highest
level
challeng
control
group
qx
pathogen
fig
b
ribv
vaccin
express
subunit
confer
full
protect
clinic
sign
associ
ibv
although
snick
rale
group
vaccin
qx
resolv
quicker
qx
challeng
control
fig
b
vaccin
beaurqx
prevent
loss
ciliari
activ
trachea
follow
challeng
homolog
wildtyp
viru
tabl
investig
tissu
tropism
ribv
rang
tissu
collect
day
postvaccin
dpv
assess
revers
transcriptionpcr
rtpcr
beaurqx
rna
detect
conjunctiva
harderian
gland
nasal
mucosaassoci
lymphoid
tissu
nalt
trachea
dpv
data
shown
histolog
analysi
headassoci
lymphoid
tissu
reveal
fig
design
ribv
construct
schemat
wildtyp
beaur
ribv
genom
gener
revers
genet
display
homolog
spike
gene
beaudett
backbon
ribv
gener
express
either
andor
ectodomain
transmembran
domain
tm
qx
wildtyp
viru
deriv
gene
repres
red
box
qx
deriv
gene
repres
green
box
ribv
beaudett
backbon
repres
solid
blue
box
endodomain
e
beaudett
repres
shade
blue
box
display
full
ectodomain
spike
previous
describ
ribv
partial
protect
ibv
journal
virolog
nfectiou
bronchiti
viru
ibv
classifi
gammacoronaviru
subfamili
coronavirina
order
nidoviral
ibv
respons
major
econom
loss
poultri
industri
worldwid
result
poor
weight
gain
decreas
egg
product
impair
egg
qualiti
effect
ibv
ciliari
activ
trachea
immun
system
may
predispos
infect
chicken
secondari
infect
opportunist
bacteria
often
increas
mortal
rate
associ
ibv
ibv
envelop
viru
singlestrand
positivesens
rna
genom
kb
encod
four
structur
protein
nucleocapsid
protein
n
spike
glycoprotein
small
membran
protein
envelop
e
integr
membran
protein
major
surfac
protein
ibv
type
glycoprotein
oligomer
form
trimer
thought
main
induc
protect
immun
protein
proteolyt
cleav
two
subunit
ntermin
subunit
approxim
amino
acid
kda
ctermin
subunit
amino
acid
kda
contain
transmembran
domain
subunit
play
critic
role
bind
cellular
receptor
sinc
contain
receptor
bind
domain
determin
viru
serotyp
respons
induct
neutral
antibodi
multipl
studi
shown
recombin
express
adenoviru
newcastl
diseas
viru
vector
induc
certain
level
protect
specifiedpathogenfre
spf
chicken
challeng
wildtyp
viru
vaccin
program
ibv
often
includ
combin
live
inactiv
vaccin
base
sever
domin
field
serotyp
viru
current
vaccin
often
induc
insuffici
crossprotect
combin
antigen
differ
vaccin
use
effort
improv
level
protect
alongsid
continu
emerg
new
field
strain
control
ibv
persist
signific
problem
poultri
industri
revers
genet
system
base
avirul
strain
ibv
beaudett
develop
system
mani
potenti
applic
enhanc
understand
role
individu
gene
pathogen
lead
new
gener
ration
design
live
attenu
vaccin
previou
work
use
revers
genet
approach
demonstr
replac
ectodomain
glycoprotein
apathogen
ibv
beaudett
strain
region
either
two
pathogen
ibv
strain
result
two
nonvirul
ribv
respect
notabl
ribv
base
beaur
backbon
acquir
cell
tropism
donor
work
demonstr
beaudett
subunit
confer
uniqu
abil
beaudett
replic
african
green
monkey
kidney
vero
cell
continu
cell
line
licens
vaccin
product
vaccin
confer
protect
homolog
challeng
base
ciliari
activ
reduct
clinic
sign
viral
load
trachea
day
postchalleng
dpc
demonstr
domin
role
glycoprotein
induc
protect
immun
studi
investig
protect
confer
homolog
challeng
two
ribv
beaurqx
contain
subunit
econom
relev
strain
qx
respect
subunit
deriv
beaur
fig
notabl
ribv
advantag
abil
replic
vero
cell
e
bickerton
et
al
unpublish
data
due
presenc
beaudett
subunit
report
first
applic
ribv
chimer
gene
use
vaccin
trial
ribv
also
investig
order
elucid
relev
role
subunit
protect
immun
subunit
consid
immunodomin
subunit
highli
conserv
strain
contain
immunogen
region
shown
vaccin
recombin
ibv
express
chimer
gene
induc
partial
protect
respons
challeng
assess
viral
load
cellular
infiltr
clinic
sign
boost
serum
antibodi
titer
postchalleng
vaccin
ribv
express
homolog
subunit
ie
full
gene
beaudett
backbon
induc
partial
protect
classifi
level
ciliari
activ
presenc
clinic
sign
follow
challeng
wildtyp
ibv
comparison
vitro
growth
characterist
show
inclus
foreign
gene
chimer
gene
ribv
imped
replic
vitro
howev
data
show
despit
abil
induc
degre
virusspecif
protect
immun
ribv
hinder
limit
vivo
replic
attenu
beaur
backbon
cellular
infiltr
harderian
gland
conjunctivaassoci
lymphoid
tissu
calt
dpv
fig
area
calt
promin
vaccin
tissu
compar
mocktreat
sampl
mock
fig
collect
find
suggest
recombin
vaccin
virus
infect
tissu
longer
detect
pcr
dpv
suggest
rapid
clearanc
site
inocul
mucos
tissu
headassoci
lymphoid
tissu
exert
virusspecif
protect
immun
respons
elucid
whether
beaurqx
abl
confer
degre
protect
homolog
challeng
evidenc
reduct
viral
load
infect
tissu
postchalleng
qpcr
conduct
assess
level
viral
rna
trachea
calt
dpc
ibv
viral
rna
load
trachea
calt
significantli
lower
vaccin
group
challeng
control
fig
c
dpc
viral
rna
load
significantli
lower
calt
beaurqx
vaccin
group
fig
infecti
viral
load
determin
titrat
trachea
tissu
supernat
tracheal
organ
cultur
toc
show
reduct
infecti
virion
recov
beaurqx
vaccin
chicken
although
reduct
signific
compar
correspond
wildtyp
control
p
beaurqx
p
fig
wildtyp
control
group
group
report
significantli
higher
infecti
viral
load
recov
trachea
compar
mockmock
control
fig
serum
ibvspecif
antibodi
assess
postvaccin
prechalleng
dpv
dpc
compar
challeng
control
group
titer
significantli
higher
beaurqx
vaccin
group
dpc
fig
b
p
p
respect
dpc
serum
titer
higher
beaurqx
vaccin
group
compar
challeng
con
wherein
bird
deem
protect
ciliostasi
fewer
tracheal
ring
per
bird
show
normal
ciliari
activ
ciliari
activ
retain
c
vaccin
consid
efficaci
confer
protect
ciliostasi
bird
group
protect
na
applic
trol
group
qxvaccin
group
significantli
higher
compar
correspond
challeng
control
group
fig
p
vaccin
group
antibodi
titer
dpv
prechalleng
could
class
borderlin
posit
due
limit
sp
cutoff
fig
summari
result
trial
suggest
although
vaccin
chicken
beaurqx
confer
complet
protect
homolog
challeng
base
clinic
sign
ciliari
activ
singl
vaccin
young
chicken
induc
partial
protect
virusspecif
immun
respons
indic
signific
reduct
viral
load
trachea
calt
higher
ibvspecif
serum
antibodi
titer
compar
challengeonli
control
show
vaccin
chimer
ribv
abl
prime
bird
challeng
whether
lack
full
protect
loss
ciliari
activ
clinic
sign
due
absenc
homolog
subunit
incorrect
fold
beaur
ribv
partial
protect
ibv
journal
virolog
therefor
lower
infectivitycould
answer
studi
therefor
second
trial
address
issu
whether
homolog
requir
protect
conduct
rel
contribut
homolog
protect
trial
ribv
use
describ
fig
experiment
design
similar
use
trial
clinic
sign
observ
vaccin
group
vaccin
data
shown
vaccin
loss
ciliari
activ
trachea
indic
apathogen
ribv
data
shown
similar
trial
dpv
chicken
challeng
clinic
sign
observ
dpc
vaccin
group
show
less
preval
clinic
sign
postchalleng
compar
challeng
control
fig
b
littl
differ
group
term
presenc
sever
clinic
sign
fig
b
vaccin
group
clinic
sign
resolv
rapidli
compar
control
ciliari
activ
assess
dpc
fig
measur
serum
antiibv
titer
beaurqx
vaccin
group
serum
titer
assess
commerci
elisa
dpc
dpc
b
group
dpc
c
qx
group
dpc
prechalleng
titer
ie
dpv
includ
panel
c
mean
sp
standard
deviat
group
n
includ
four
technic
replicatesanim
dash
line
show
cutoff
posit
sampl
sp
solid
bar
denot
trend
statist
signific
across
dilut
comparison
mockchallengeonli
group
eg
beaurqx
qx
compar
mockqx
compar
p
show
improv
level
protect
comparison
group
vaccin
protect
group
evid
tabl
noteworthi
assess
individu
bird
level
show
three
five
bird
class
protect
ciliostasi
howev
sinc
group
averag
translat
protect
group
level
tabl
viral
rna
load
trachea
calt
isol
challeng
chicken
determin
qpcr
elucid
whether
subunit
play
role
confer
protect
dpc
calt
vaccin
chicken
show
signific
reduct
p
viral
rna
load
compar
challeng
control
fig
howev
dpc
group
significantli
lower
viral
rna
load
calt
p
p
failur
locat
ribv
headassoci
lymphoid
respiratori
tissu
dpv
trial
led
inclus
time
point
trial
detect
rtpcr
number
harderian
gland
trachea
isol
chicken
dpv
howev
dpv
ribv
mainli
detect
nasal
turbin
tabl
suggest
rapid
clearanc
ribv
mucos
head
tissu
site
inocul
although
titer
infecti
challeng
viru
recov
trachea
dpc
significantli
reduc
vaccin
chicken
compar
control
variat
within
group
gener
trend
vaccin
result
reduct
viral
infect
detect
infecti
viru
recov
four
five
bird
group
three
five
bird
group
one
five
bird
group
fig
collect
show
chimer
ribv
abl
induc
degre
local
protect
replic
ibv
trachea
assess
whether
ribv
induc
humor
antibodi
respons
follow
vaccin
virus
ibvspecif
serum
titer
assess
dpc
dpc
clear
evid
boost
antibodi
titer
vaccin
group
fig
significantli
higher
titer
compar
control
p
ibv
induc
antibodi
titer
dpc
vaccin
chicken
higher
vaccin
chicken
across
dilut
seri
fig
dpc
serum
antibodi
titer
vaccin
group
significantli
wherein
bird
deem
protect
ciliostasi
fewer
tracheal
ring
per
bird
show
normal
ciliari
activ
ciliari
activ
retain
c
vaccin
consid
efficaci
confer
protect
ciliostasi
bird
group
protect
na
applic
higher
compar
titer
fig
observ
suggest
prime
antibodi
respons
vaccin
chicken
serum
antibodi
titer
dpc
indic
signific
differ
vaccin
group
challengeonli
control
fig
suggest
boost
respons
lack
respons
challeng
wildtyp
viru
viru
neutral
activ
serum
collect
dpc
assess
dpc
neutral
viru
detect
data
shown
dpc
serum
vaccin
chicken
significantli
higher
neutral
activ
viru
compar
mockmock
control
p
p
respect
fig
vaccin
induc
significantli
higher
viru
neutral
titer
compar
beaur
follow
observ
differ
vivo
vaccin
trial
elucid
whether
inclus
chimer
gene
foreign
gene
effect
viral
replic
replic
kinet
ribv
virus
investig
vitro
h
postinfect
hpi
virus
similar
titer
fig
b
suggest
inclus
foreign
gene
chimer
gene
imped
replic
vitro
either
chicken
kidney
cell
ckc
deriv
valo
chicken
fig
ckc
deriv
rhode
island
red
rir
bird
fig
singlestep
growth
curv
perform
ckc
deriv
rir
bird
show
latent
period
hpi
lower
viru
titer
compar
virus
howev
exponenti
growth
compar
statist
differ
virus
fig
titer
similar
across
time
point
fig
previous
shown
ribv
express
ectodomain
spike
protein
pathogen
strain
context
apathogen
strain
beaur
could
induc
increas
level
protect
homolog
partial
heterolog
challeng
infect
extend
work
replac
subunit
ectodomain
beaur
domain
qx
repres
two
strain
circul
poultri
flock
worldwid
ribv
advantag
ribv
partial
protect
ibv
journal
virolog
abl
replic
vero
cell
potenti
allow
largescal
vaccin
product
cell
cultur
rather
embryon
egg
first
vaccin
studi
use
singl
dose
beaurqx
chick
bird
protect
homolog
challeng
base
ciliari
activ
clinic
sign
vaccin
beaurqx
induc
significantli
higher
serum
titer
postchalleng
clinic
sign
associ
challeng
viru
although
present
decreas
rapidli
compar
unvaccin
bird
challeng
qx
togeth
data
show
vaccin
chimer
ribv
abl
induc
degre
virusspecif
immun
partial
local
protect
mucos
head
tissu
primari
site
replic
trachea
address
question
whether
full
homolog
requir
optim
fold
viru
replic
protect
use
apathogen
recombin
viru
second
vaccin
experi
perform
oneweekold
bird
immun
replac
apathogen
subunit
pathogen
strain
allow
beaur
remain
apathogen
suggest
alon
play
role
pathogen
ibv
expand
previou
work
show
spike
switch
beaur
effect
pathogen
vaccin
chicken
ribv
base
beaur
backbon
express
full
gene
donor
serotyp
enhanc
level
protect
afford
tracheal
ciliostasi
three
five
bird
class
fulli
protect
howev
classifi
european
pharmacopeia
standard
assess
ibv
vaccin
protect
group
level
ciliostasi
requir
vaccin
group
abl
confer
partial
protect
therefor
still
satisfactori
criteria
use
assess
ibv
vaccin
industri
applic
consist
previous
publish
work
show
collect
group
chicken
vaccin
via
ocularnas
rout
ciliari
activ
remain
reduct
clinic
sign
viral
load
postchalleng
protect
seen
trachea
may
potenti
improv
assess
ciliostasi
later
time
point
armesto
et
al
report
vaccin
gave
ciliari
activ
dpc
improv
dpc
trial
viral
rna
load
trachea
calt
group
reduc
dpc
wherea
trial
vaccin
group
clear
signific
reduct
viral
rna
load
dpc
trachea
calt
qpcr
use
design
detect
untransl
region
utr
genom
therefor
may
detect
incomplet
virion
challeng
viru
captur
lumen
trachea
support
viral
rna
load
data
infecti
viral
load
recov
trachea
trial
lower
ribvvaccin
chicken
indic
degre
local
protect
site
infect
robust
enough
complet
protect
viral
replic
vivo
loss
ciliari
activ
major
surfac
glycoprotein
coronavirus
spike
type
glycoprotein
two
structur
distinct
conform
prefus
postfus
coronaviru
replic
cycl
spike
mediat
critic
step
receptor
bind
membran
fusion
upon
bind
receptor
bind
domain
host
cell
irrevers
conform
switch
postfus
state
allow
subunit
fuse
viral
cellular
membran
facilit
entri
viral
genom
therefor
downstream
viral
replic
recent
crystal
structur
prefus
spike
mous
hepat
viru
human
coronaviru
resolv
highlight
critic
role
interact
trimer
play
stabil
prefus
conform
spike
express
chimer
spike
recombin
ibv
backbon
lack
homolog
possibl
result
conform
chang
either
within
subunit
complet
protein
potenti
affect
receptor
bind
entri
may
also
alter
immunogen
epitop
subunit
beaur
share
amino
acid
sequenc
similar
qx
respect
show
differ
amino
acid
residu
interact
subunit
critic
mainten
conform
recognit
effici
fusion
spike
host
cell
consist
shown
even
singl
amino
acid
chang
within
subunit
coronaviru
spike
may
influenc
secondari
structur
overal
spike
subunit
develop
cryoelectron
microscop
structur
ibv
spike
highlight
evolutionari
differ
prefus
spike
structur
ibv
compar
betacoronavirus
alphacoronavirus
nonetheless
indic
high
degre
structur
similar
porcin
deltacoronaviru
structur
model
prefus
ibv
spike
significantli
aid
address
challeng
whether
express
chimer
spike
ribv
backbon
caus
conform
chang
either
within
subunit
complet
ii
vital
homolog
match
interact
requir
maintain
correct
prefus
conform
spike
suggest
coronavirus
beaudett
strain
use
revers
genet
system
extend
vitro
tropism
abil
grow
cell
cultur
apathogen
natur
make
excel
resourc
investig
heterolog
gene
growth
characterist
ribv
embryo
passag
howev
beaudett
strain
may
acquir
mutat
like
contribut
lack
pathogen
restrict
vivo
tropism
replic
replac
beaur
correspond
subunit
pathogen
strain
indic
signific
impair
vitro
growth
virus
comparison
beaur
viru
show
indic
unabl
enter
cell
fuse
cell
membran
fail
replic
vitro
nevertheless
lack
full
protect
afford
beaur
ribv
wildtyp
challeng
limit
vivo
replic
strongli
suggest
attenu
occur
gene
play
essenti
role
replic
neg
impact
suitabl
vaccin
vector
develop
altern
lessattenu
backbon
express
heterolog
gene
ribv
may
promot
develop
live
attenu
vaccin
control
ibv
express
ibv
subunit
alon
shown
induc
virusneutr
antibodi
albeit
often
requir
repeat
vaccin
immun
chicken
ribv
base
beaudett
backbon
express
either
chimer
induc
virusneutr
antibodi
howev
serum
also
degre
neutral
activ
vaccin
chicken
significantli
higher
viru
neutral
titer
group
statist
differ
group
show
neutral
antibodi
induc
follow
singl
vaccin
ribv
express
live
attenu
vaccin
ibv
need
induc
good
level
mucos
immun
local
tracheal
cellmedi
immun
also
play
import
role
prevent
ibv
infect
discuss
earlier
beaur
backbon
imped
poor
vivo
replic
lack
protect
shown
ciliostasi
indic
poor
level
local
immun
induc
trachea
vaccin
beaur
ribv
cytotox
respons
also
play
key
role
earli
control
ibv
indic
previou
studi
show
nk
cell
activ
ibvspecif
cytotox
tcelllymphocyt
ctl
activ
splenocyt
isol
ibvinfect
chicken
higher
ctl
proport
respiratori
tissu
follow
ibv
infect
cellular
infiltr
headassoci
lymphoid
tissu
well
reduct
viral
load
trachea
calt
also
impli
ribv
infect
chicken
suggest
possibl
role
cellmedi
respons
howev
unabl
consist
detect
recombin
virus
dpv
rais
possibl
virus
either
rapidli
clear
tissu
replic
poorli
site
inocul
limit
replic
cell
detect
limit
assay
vaccin
group
chicken
posit
vaccin
viru
assess
rtpcr
harderian
gland
nasal
turbin
dpv
respect
primari
site
ibv
infect
thought
ciliat
epithelium
line
trachea
howev
follow
ocularnas
vaccin
viru
detect
nasal
turbin
harderian
gland
one
possibl
explan
poor
protect
ciliari
activ
afford
recombin
virus
could
administ
singl
vaccin
dose
spf
chick
previou
studi
use
baculoviru
express
ibv
recombin
protein
ibv
purifi
protein
requir
multipl
inject
achiev
degre
protect
spf
chicken
also
evid
impair
humor
respons
young
chick
regard
ibv
vaccin
vaccin
chick
show
delay
system
local
iga
igg
level
compar
vaccin
older
chick
day
old
attempt
improv
protect
respiratori
sign
ciliostasi
recombin
virus
primeboost
approach
may
aid
overcom
potenti
issu
summari
previous
gener
recombin
ibv
base
beaur
backbon
express
heterolog
qx
present
studi
shown
singl
vaccin
young
chick
ribv
although
adequ
complet
prevent
ciliostasi
clinic
sign
induc
degre
virusspecif
protect
immun
character
reduct
viral
load
recov
trachea
calt
cellular
infiltr
head
mucos
inocul
site
higher
serum
antibodi
titer
vaccin
group
induct
virusneutr
activ
vaccin
despit
express
homolog
full
attempt
overcom
issu
heterolog
subunit
suboptim
fold
induc
partial
protect
loss
ciliari
activ
sinc
vitro
growth
characterist
show
inclus
foreign
gene
chimer
gene
ribv
imped
replic
vitro
perhap
attenu
beaudett
backbon
hinder
vivo
replic
ribv
thu
improv
protect
multipl
vaccin
altern
backbon
may
requir
ethic
statement
anim
experiment
protocol
carri
strict
accord
uk
home
offic
guidelin
licens
grant
experi
involv
regul
procedur
anim
protect
uk
anim
scientif
procedur
act
experi
perform
pirbright
institut
tpi
home
offic
licens
experiment
anim
hous
facil
approv
tpi
anim
welfar
ethic
review
committe
term
refer
trial
use
spf
rir
chicken
obtain
tpi
poultri
product
unit
compton
trial
use
chicken
breed
obtain
nation
avian
research
facil
edinburgh
cell
virus
tracheal
organ
cultur
toc
prepar
spf
rir
chicken
embryo
primari
chicken
kidney
ck
cell
prepar
central
servic
unit
tpi
kidney
extract
either
spf
rir
chicken
spf
deriv
valo
chicken
pathogen
strain
use
studi
previous
adapt
ck
cell
produc
access
number
pathogen
strain
qx
qx
strain
access
number
donat
richard
jone
univers
liverpool
ribv
beaurqx
use
describ
schemat
illustr
fig
construct
use
backbon
beaur
molecular
clone
beauck
access
number
isol
ibv
ribv
propag
rir
spf
embryon
egg
allanto
fluid
clarifi
lowspe
centrifug
hpi
titrat
determin
viru
infect
either
perform
toc
describ
previous
ck
cell
titer
express
median
ciliostat
dose
cd
ml
pfuml
respect
analysi
growth
kinet
ck
cell
confluent
ck
cell
seed
either
plate
inocul
pfu
ribv
ibv
multistep
growth
curv
pfu
ribv
ibv
singlestep
growth
curv
ml
serumfre
n
nbi
acid
be
medium
incub
h
co
cell
wash
phosphatebuff
salin
pb
remov
residu
viru
ml
serumfre
be
medium
ad
per
well
extracellular
viru
harvest
defin
interv
assay
titrat
ck
cell
experiment
design
vivo
vaccinationchalleng
trial
spf
rir
chicken
hous
positivepressur
hepafilt
isol
room
group
hous
separ
room
two
separ
experi
bird
randomli
divid
group
bird
trial
group
bird
trial
eightdayold
chick
inocul
classifi
primari
inocul
pfu
beaurqx
trial
pfu
trial
total
ml
pb
via
conjunctiv
eye
drop
intranas
rout
challeng
dose
equal
primari
inocul
pfu
trial
pfu
trial
correspond
wildtyp
virus
administ
manner
day
primari
inocul
appropri
group
note
ibv
qx
strain
use
could
propag
ck
cell
cd
dose
use
mockinfect
control
inocul
via
rout
ml
pb
mock
challeng
control
group
inocul
ml
pb
challeng
dose
wildtyp
viru
bird
euthan
cervic
disloc
specif
time
postinfect
panel
tissu
sampl
allow
downstream
analysi
blood
sampl
collect
process
collect
serum
clinic
sign
use
determin
pathogen
snick
rale
ciliari
activ
trachea
bird
consid
protect
ciliari
activ
retain
tracheal
ring
must
group
isol
tissu
viru
isol
ciliostasi
assay
tissu
collect
divid
two
part
one
part
stabil
rnalat
ambion
rna
extract
sucrosepb
size
filter
overnight
snap
freez
oct
thermo
scientif
histolog
tissu
collect
includ
harderian
gland
calt
nalt
trachea
tissu
remov
day
postvaccin
dpv
day
postchalleng
dpc
trachea
remov
five
randomli
select
chicken
group
dpv
dpc
assess
ciliari
activ
describ
previous
part
trachea
calt
tissu
store
pb
viru
isol
detect
viral
rna
viru
isol
rna
extract
tissu
store
pb
rnalat
respect
freezethaw
homogen
use
tissuelys
ii
qiagen
describ
previous
total
rna
isol
use
rneasi
minikit
dnase
treat
accord
manufactur
instruct
qiagen
cdna
synthes
g
trna
use
superscript
iv
revers
transcriptas
life
technolog
random
oligonucleotid
primer
accord
manufactur
instruct
quantifi
infecti
viral
load
trachea
tissuederiv
supernat
titrat
toc
determin
whether
infecti
viru
present
spf
embryon
egg
inocul
l
allanto
fluid
hpi
assess
viral
presenc
rtpcr
use
primer
specif
utr
describ
previous
quantif
viral
load
qpcr
perform
use
taqman
univers
pcr
master
mix
appli
biosystem
primer
probe
specif
region
describ
previous
serial
dilut
cdna
gener
g
trna
includ
gener
standard
curv
data
express
term
cycl
threshold
c
valu
normal
use
c
valu
cdna
product
sampl
infecti
bronchiti
viru
elisa
serum
sampl
collect
dpv
prechalleng
dpc
assay
commerci
idexx
ibv
antibodi
test
kit
idexx
laboratori
determin
endpoint
titer
serum
sampl
twofold
serial
dilut
rang
prior
ribv
partial
protect
ibv
journal
virolog
incub
sampl
incub
remain
step
follow
directli
accord
manufactur
instruct
sampleposit
sp
ratio
calcul
use
follow
equat
mean
sampl
mean
kit
neg
mean
kit
posit
mean
kit
neg
sp
ratio
greater
consid
posit
ibv
antibodi
polyclon
chicken
serum
rais
qx
serum
includ
independ
test
plate
gd
anim
health
immunocytochemistri
fluoresc
microscopi
cryostat
section
fix
aceton
wash
pb
block
h
room
temperatur
normal
goat
serum
bovin
serum
albumin
pb
block
buffer
slide
wash
incub
h
optim
dilut
primari
antibodi
clone
abd
serotec
clone
abd
serotec
clone
abd
serotec
isotyp
control
dilut
block
buffer
section
wash
incub
alexa
fluor
goat
antimous
alexa
fluor
goat
antimous
accord
appropri
isotyp
dilut
block
buffer
h
nuclei
visual
use
dapi
invitrogen
imag
captur
leica
dmlb
fluoresc
microscop
coupl
devic
digit
camera
analyz
use
imagej
analysi
softwar
light
microscopi
cryostat
section
fix
aceton
stain
harri
hematoxylin
sigmaaldrich
eosin
sigmaaldrich
section
dehydr
grade
ethanol
xylen
mount
xylenebas
medium
depex
gurrbdh
chemic
imag
captur
hamamatsu
nanozoomerxr
digit
slide
scanner
analysi
neutral
antibodi
viru
neutral
test
perform
gd
anim
health
briefli
twofold
serial
dilut
serum
made
mixtur
ham
plate
well
equal
volum
cek
cell
medium
supplement
fetal
calf
serum
ad
cultur
day
co
cell
monolay
examin
cytopath
effect
cpe
individu
titer
express
log
valu
reciproc
highest
serum
dilut
show
complet
inhibit
cpe
statist
analys
viral
load
qpcr
data
test
normal
residu
plot
differ
mean
correct
valu
statist
evalu
parametr
oneway
analysi
varianc
test
adjust
post
hoc
analysi
use
tukey
pairwis
comparison
serum
antibodi
level
viral
isol
titer
ciliari
activ
viru
neutral
titer
test
normal
nonparametr
analys
perform
differ
group
statist
evalu
nonparametr
kruskalw
test
adjust
post
hoc
analysi
mannwhitney
u
pairwis
comparison
relationship
antiibv
serum
viru
neutral
titer
compar
spearman
rank
correl
analysi
analysi
viral
growth
curv
conduct
fit
polynomi
curv
exponenti
phase
viral
growth
growth
rate
compar
group
use
nonparametr
kruskalw
test
adjust
post
hoc
analysi
statist
analys
p
valu
consid
signific
statist
analys
conduct
use
minitab
graphpad
prism
